Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/16/1995 | WO1995022258A3 Isolation of lactoferrin from milk |
11/16/1995 | WO1995019371A3 Expression of surface layer proteins |
11/16/1995 | WO1995018862A3 Tfda gene selectable markers in plants and the use thereof |
11/16/1995 | EP0690919A4 Crucifer acc synthase and uses thereof |
11/16/1995 | DE19517773A1 Rekombinante PRRSV-Proteine, Diagnostik-Kits und solche rekombinanten PRRSV-Proteine enthaltenden Vakzinen Recombinant PRRSV proteins, diagnostic kits and such recombinant PRRSV proteins containing vaccines |
11/16/1995 | CA2189980A1 Thermostable alkaline phosphatase of thermus thermophilus |
11/16/1995 | CA2189774A1 Recombinant hk2 polypeptide |
11/16/1995 | CA2189638A1 Method of detecting human cytochrome p4502d6 gene polymorphism |
11/16/1995 | CA2189582A1 Sv-40 derived dna constructs comprising exogenous dna sequences |
11/16/1995 | CA2189452A1 Methods of in vivo gene delivery |
11/16/1995 | CA2188795A1 Chimeric delta-endotoxin expression in pseudomonas fluorescens |
11/16/1995 | CA2188453A1 Light-regulated promoters for production of heterologous proteins in filamentous fungi |
11/16/1995 | CA2188450A1 Neurogenic differentiation (neurod) genes and proteins |
11/16/1995 | CA2187534A1 Improved bacillus thuringiensis .delta.-endotoxin |
11/16/1995 | CA2186621A1 Lanthionine-containing antimicrobial compound |
11/16/1995 | CA2158977A1 Retroviral vectors having a reduced recombination rate |
11/15/1995 | EP0682257A1 Methods of detecting collagen degradation in vivo |
11/15/1995 | EP0682256A1 Methods of detecting collagen degradation in vivo |
11/15/1995 | EP0682120A1 Selective amplification of target polynucleotide sequences |
11/15/1995 | EP0682117A1 Dna coding for carbonic anhydrase |
11/15/1995 | EP0682116A1 Ascorbate oxidase, gene encoding the same, process for producing the same, and reagent composition using the same |
11/15/1995 | EP0682115A1 Synthetic insecticidal crystal protein gene |
11/15/1995 | EP0682114A2 Expression of recombinant MPF-4, CPF-4, PF-4 and precursor compounds |
11/15/1995 | EP0682113A2 Polypeptide produced in an endothelial cell line and DNA encoding it |
11/15/1995 | EP0682112A1 Method for archiving expression, or to improve the level of expression of a gene |
11/15/1995 | EP0682111A1 Chimeric or transgenic animal and process for screening pharmaceutical products |
11/15/1995 | EP0682110A1 Recombinant DNA encoding PDGF A-chain polypeptides |
11/15/1995 | EP0682040A1 Humanized immunoglobulins and their production and use |
11/15/1995 | EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof |
11/15/1995 | EP0681842A2 Ligand-mediated immunofunctional hormone binding protein assay method |
11/15/1995 | EP0681613A1 Ribozyme amplified diagnostics |
11/15/1995 | EP0681610A1 Polypeptides having amidase activity, genetic tools and host microorganisms for obtaining same |
11/15/1995 | EP0681609A1 A process for the preparation of lipase |
11/15/1995 | EP0681588A1 Max-interacting proteins and related molecules and methods |
11/15/1995 | EP0681585A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
11/15/1995 | EP0681483A1 Compositions and methods for delivery of genetic material |
11/15/1995 | EP0681482A1 Localization of therapeutic agents |
11/15/1995 | EP0681477A1 Genetic modification of neural stem cells |
11/15/1995 | EP0681470A1 Recombinant living subunit vaccine composition and process for its preparation. |
11/15/1995 | EP0681431A1 Production of human recombinant collagen in the milk of transgenic animals |
11/15/1995 | EP0681427A1 Tomato spotted wilt virus |
11/15/1995 | EP0618930A4 Monoclonal antibody to hiv-2 and uses thereof. |
11/15/1995 | EP0530357B1 Element and method for nucleic acid amplification and detection using adhered probes |
11/15/1995 | EP0527977B1 Nematode vaccine |
11/15/1995 | EP0469021B1 Determination of factors affecting gene regulation and/or gene replication |
11/15/1995 | EP0448707B1 Bacteria harboring expression vectors encoding human CILIARY NEUROTROPHIC FACTOR (h-CNTF), their use in the production of h-CNTF, antibodies to h-CNTF and the use of h-CNTF in medical treatment |
11/15/1995 | CN1111910A Mammamodulin, a hormone-independent mammary tumor cells specific protein |
11/15/1995 | CN1111909A Novel polypeptide and DNA coding for the same |
11/15/1995 | CN1111676A Expression system, integration vector and cell transformed by this integration vector |
11/14/1995 | US5466792 RI T-DNA Promoters |
11/14/1995 | US5466788 Subgenomic promoter |
11/14/1995 | US5466786 2'modified nucleoside and nucleotide compounds |
11/14/1995 | US5466785 Tissue-preferential promoters |
11/14/1995 | US5466783 Human tissue factor inhibitor |
11/14/1995 | US5466676 Satellite cell proliferation in adult skeletal muscle |
11/14/1995 | US5466598 Deacetylcephalosporin C acetyltransferase from Acremonium chrysogenum |
11/14/1995 | US5466597 Bacillus thuringiensis strains and their genes encoding insecticidal toxins |
11/14/1995 | US5466596 Genetic engineering |
11/14/1995 | US5466595 Calcium independent cytosolic phospholipase A2/B enzymes |
11/14/1995 | US5466593 DNA fragments and gene expression |
11/14/1995 | US5466592 Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom |
11/14/1995 | US5466591 Enzyme mutants |
11/14/1995 | US5466590 Constitutive expression of P450soy and ferredoxin-soy in Streptomyces |
11/14/1995 | US5466589 Coated substrates employing oriented layers of mutant heme proteins and methods of making and using same |
11/14/1995 | US5466587 Method for introducing a biological substance into a target |
11/14/1995 | US5466586 Method for the synthesis of ribonucleic acid (RNA) |
11/14/1995 | US5466584 Oxytocin receptor and DNA coding therefor |
11/14/1995 | US5466577 Nucleic acid probes for the detection of Lyme disease spirochetes |
11/14/1995 | US5466576 Modulation of PIF-1-type helicases |
11/14/1995 | CA1337552C In-vitro headful packaging system for cloning dna fragments as large as 95 kb |
11/14/1995 | CA1337551C Accelerated nucleic acid reassociation method |
11/10/1995 | CA2148898A1 P54 stress-activated protein kinases |
11/10/1995 | CA2148301A1 Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds |
11/09/1995 | WO1995030326A1 Neural receptor tyrosine kinase |
11/09/1995 | WO1995030139A1 System for real time detection of nucleic acid amplification products |
11/09/1995 | WO1995030026A1 Transcription factor-dna binding assay |
11/09/1995 | WO1995030019A1 Feline immunodeficiency virus vaccine |
11/09/1995 | WO1995030018A2 Recombinant poxviruses with foreign polynucleotides in essential regions |
11/09/1995 | WO1995030017A1 Improvements in or relating to disease-resistance of plants |
11/09/1995 | WO1995030016A1 Methods for peptide synthesis and purification |
11/09/1995 | WO1995030014A1 Bifunctional protein, preparation and use |
11/09/1995 | WO1995030013A1 Human-origin prostacyclin synthase |
11/09/1995 | WO1995030012A1 Functional expression of mammalian adenylyl cyclase in yeast |
11/09/1995 | WO1995030011A2 Subtilisin 309 variants having decreased adsorption and increased hydrolysis |
11/09/1995 | WO1995030010A1 Subtilisin bpn' variants having decreased adsorption and increased hydrolysis |
11/09/1995 | WO1995030009A2 Identification, production and use of saponin glyclosyl hydrolases |
11/09/1995 | WO1995030008A1 Density enhanced protein tyrosine phosphatases |
11/09/1995 | WO1995030007A1 Thymidine kinase mutants |
11/09/1995 | WO1995030006A1 Leishmania major protein, nucleic acid coding therefor, and uses thereof |
11/09/1995 | WO1995030005A1 Genes regulating the response of zea mays to water deficit |
11/09/1995 | WO1995030004A1 Monoclonal antibodies which promote central nervous system remyelination |
11/09/1995 | WO1995030003A2 Morphogenic protein-specific cell surface receptors and uses therefor |
11/09/1995 | WO1995030002A2 Enhancing the sensitivity of tumor cells to therapies |
11/09/1995 | WO1995030000A1 Dna sequences |
11/09/1995 | WO1995029996A1 Alkaline glucose oxidase |
11/09/1995 | WO1995029993A1 Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line |
11/09/1995 | WO1995029992A1 Method for purifying chromosomes and hybrid muntjac cell lines containing foreign chromosomes |
11/09/1995 | WO1995029979A1 Fabric cleaning compositions containing subtilisin bpn' variants |
11/09/1995 | WO1995029935A1 Method for proliferating and differentiating b cells, and uses thereof |
11/09/1995 | WO1995029703A1 Introduction of hiv-protective genes into cells by particle-mediated gene transfer |